We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
UK agency NICE, which provides guidance on pharmaceuticals to be reimbursed
by the NHS, has published an assessment on the use of statins for the prevention
of coronary heart disease.
Auxilium Pharmaceuticals, a specialty pharmaceutical company that develops and
markets products for urology and sexual health, announced it has entered into
definitive agreements with institutional and other accredited investors, including
existing stockholders and affiliated entities, for the private placement of
approximately 8.2 million shares of common stock at a price of approximately
$4.90 per share, together with warrants to purchase approximately 2.06 million
additional shares of common stock at an exercise price of $5.84 per share, for
a total purchase price of $40.4 million.
Cougar Biotechnology, a privately held biotechnology company, today announced
that it has licensed the worldwide, exclusive rights to seocalcitol from Dutch
firm LEO Pharma A/S. Seocalcitol (EB1089) is a synthetic analog of vitamin D
that has been clinically tested in a number of different cancer indications.
Caprion Pharmaceuticals announced that Wyeth has expanded a previously announced
collaboration in the discovery and development of protein biomarkers to include
two clinical programs currently underway at Wyeth.
ChemGenex Pharmaceuticals, based in Melbourne, Australia and Menlo Park, Calif.,
and Stragen Pharma, based in Geneva, Switzerland, announced an international
alliance to accelerate the clinical development of ChemGenex's lead anti-cancer
therapeutic, Ceflatonin.
Officials in the East African state of Uganda have reiterated that imports of
generic ARVs tentatively approved under the US government's PEPFAR accelerated
review plan will be banned.